CLINICAL_TRIALS
trial_result
· 2026-04-08
Clinical Trial Update: A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study [Phase 3]
Summary
Phase 3 long-term safety study of Iclepertin in schizophrenia participants has been terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED | Results posted: 2026-04-08